{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:46:40Z","timestamp":1782773200134,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.urolonc.2024.03.014","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T20:51:41Z","timestamp":1713991901000},"page":"246.e15-246.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-7214","authenticated-orcid":false,"given":"Carmen","family":"G\u00f3mez del Ca\u00f1izo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3693-9957","authenticated-orcid":false,"given":"Ignacio","family":"Gonz\u00e1lez Ginel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-2811","authenticated-orcid":false,"given":"Cristina","family":"Mart\u00edn-Arriscado Arroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6599-4153","authenticated-orcid":false,"given":"Ana","family":"de la Calle Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5122-2936","authenticated-orcid":false,"given":"Mario","family":"Hern\u00e1ndez Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7841-708X","authenticated-orcid":false,"given":"Alfredo","family":"Rodr\u00edguez Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-3465","authenticated-orcid":false,"given":"F\u00e9lix","family":"Guerrero Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.03.014_bib0001","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory [Website]. 2020 [updated 03\/11\/2021]. Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/30-Bladder-fact-sheet.pdf."},{"key":"10.1016\/j.urolonc.2024.03.014_bib0002","unstructured":"Babjuk M, Burger M, Comp\u00e9rat E, Gontero P, Mostafid A, Palou J, et al. EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2020. 2020."},{"key":"10.1016\/j.urolonc.2024.03.014_bib0003","series-title":"Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urologic oncology: seminars and original investigations","author":"Yafi","year":"2015"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0004","doi-asserted-by":"crossref","unstructured":"Beyer-Boon M, De Voogt H, Van der Velde E, Brussee J, Schaberg AJUr. The efficacy of urinary cytology in the detection of urothelial tumours. 1978;6(1):3\u201312.","DOI":"10.1007\/BF00257076"},{"issue":"Suppl 2","key":"10.1016\/j.urolonc.2024.03.014_bib0005","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/modpathol.2008.193","article-title":"Diagnosis of urothelial carcinoma from urine","volume":"22","author":"T\u00eatu","year":"2009","journal-title":"Modern Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.03.014_bib0006","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejso.2004.12.008","article-title":"The role of urinary cytology for detection of bladder cancer","volume":"31","author":"Planz","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0007","doi-asserted-by":"crossref","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Escrig JLD, et al. European association of urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). 2021.","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0008","doi-asserted-by":"crossref","unstructured":"Brimo F, Vollmer RT, Case B, Aprikian A, Kassouf W, Auger MJAjocp. Accuracy of urine cytology and the significance of an atypical category. 2009;132(5):785\u201393.","DOI":"10.1309\/AJCPPRZLG9KT9AXL"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0009","unstructured":"Guerrero-Ramos F, Subiela JD, Rodr\u00edguez-Faba \u00d3, Aumatell J, Manfredi C, Bozzini G, et al. Predicting recurrence and progression in patients with non-muscle-invasive bladder cancer: systematic review on the performance of risk stratification models. (Preprint):1-19."},{"key":"10.1016\/j.urolonc.2024.03.014_bib0010","unstructured":"EORTC. EORTC risk tables for bladder cancer 2022 [Available from: https:\/\/www.eortc.be\/tools\/bladdercalculator\/."},{"issue":"9","key":"10.1016\/j.urolonc.2024.03.014_bib0011","first-page":"574","article-title":"New immunotherapies for high-risk non-muscle invasive bladder cancer","volume":"44","author":"Del Ca\u00f1izo","year":"2020","journal-title":"Curr State Fut Perspect"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0012","unstructured":"US National Lybrary of Medicine. Clinicaltrials on nonmuscle invasive bladder cancer: National Library of Medicine; 2024 [cited 2024]. Available from: https:\/\/clinicaltrials.gov\/search?cond=Nonmuscle%20Invasive%20Bladder%20Cancer."},{"key":"10.1016\/j.urolonc.2024.03.014_bib0013","series-title":"BladderGATE: Atezolizumab+ intravesical BCG (bacillus Calmette-Guerin) upfront combination in patients with high risk non-muscle invasive bladder cancer (NMIBC)\u2014Phase I-II ONCOSUR study. Abstract 595. Chicago","author":"Castellano","year":"2024"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0014","doi-asserted-by":"crossref","unstructured":"Koga F, Kobayashi S, Fujii Y, et al. Significance of positive urine cytology on progression and cancer-specific mortality of non\u2013muscle-invasive bladder cancer. 2014;12(3):e87\u2013e93.","DOI":"10.1016\/j.clgc.2013.07.007"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0015","doi-asserted-by":"crossref","unstructured":"Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris system for reporting urinary cytology: the quest to develop a standardized terminology. 2016;60(3):185\u201397.","DOI":"10.1159\/000446270"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0016","doi-asserted-by":"crossref","unstructured":"Onder S, Kurtulan O, Kavuncuoglu A, Akdogan BJJoC. Comparison of diagnostic performances of urine cytology before and after the use of the paris system criteria: an institutional experience from Turkey. 2021;38(3):133.","DOI":"10.4103\/JOC.JOC_38_21"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0017","doi-asserted-by":"crossref","unstructured":"Rohra P, Ocampo Gonzalez FA, Yan L, Mir F, Furlan K, Basu S, et al. Effect of the Paris system for reporting urinary cytology with histologic follow-up. 2021;49(6):691\u20139.","DOI":"10.1002\/dc.24723"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0018","doi-asserted-by":"crossref","unstructured":"Sahai R, Rajkumar B, Joshi P, Singh A, Kumar A, Durgapal P, et al. Interobserver reproducibility of the Paris system of reporting urine cytology on cytocentrifuged samples. 2020;48(11):979\u201385.","DOI":"10.1002\/dc.24476"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0019","doi-asserted-by":"crossref","unstructured":"Witjes JA, Morote J, Cornel EB, Gakis G, van Valenberg FJP, Lozano F, et al. Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non\u2013muscle-invasive bladder Cancer: results of a multicenter, prospective, blinded clinical trial. 2018;1(4):307\u201313.","DOI":"10.1016\/j.euo.2018.06.011"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0020","first-page":"1087","article-title":"Clinical utility of cxbladder for the diagnosis of urothelial carcinom","volume":"34","author":"Darling","year":"2017","journal-title":"Astron"},{"key":"10.1016\/j.urolonc.2024.03.014_bib0021","series-title":"UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urologic oncology: seminars and original investigations","year":"2008"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:07:14Z","timestamp":1717308434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924004010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1078143924004010"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}